{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:02:43Z","timestamp":1790852563385,"version":"4.1.0"},"reference-count":61,"publisher":"American Association for Cancer Research (AACR)","issue":"1","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The roles played by host-derived nitric oxide (NO) in the growth and subsequent immune rejection of a immunogenic murine lymphoma were investigated by growing the tumor in mice in which the gene for either inducible NO synthase (iNOS) or endothelial NOS (eNOS) had been ablated. This showed that NO from tumor-infiltrating host cells had no significant effect on either tumor growth or immune rejection, although measurements of tumor nitrite levels and protein nitration showed that there had been significant NO production in the rejected tumors, in both the eNOS and iNOS knockout mice. Inhibition of both tumor and host NOS activities, with an iNOS-selective inhibitor (1400W), a nonselective NOS inhibitor [N\u03c9-nitro-l-arginine methyl ester (L-NAME)], or scavenging NO with a ruthenium-based scavenger, significantly delayed tumor rejection, while having no appreciable effect on tumor growth. Incubation of tumor cells with medium taken from cultured splenocytes, that had been isolated from immunized animals and activated by incubating them with irradiated tumor cells, resulted in an increase in tumor cell NOS activity and an increase in tumor cell apoptosis, which could be inhibited using L-NAME. We propose that, during the immune rejection of this tumor model, there is induction of tumor NOS activity by cytokines secreted by activated lymphocytes within the tumor and that this results in increased levels of tumor NO that induce tumor cell apoptosis and facilitate immune rejection of the tumor.<\/jats:p>","DOI":"10.1158\/0008-5472.can-03-1807","type":"journal-article","created":{"date-parts":[[2005,9,20]],"date-time":"2005-09-20T22:35:47Z","timestamp":1127255747000},"page":"152-161","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Tumor Cell-Derived Nitric Oxide Is Involved in the Immune-Rejection of an Immunogenic Murine Lymphoma"],"prefix":"10.1158","volume":"64","author":[{"given":"De-En","family":"Hu","sequence":"first","affiliation":[{"name":"1Department of Biochemistry, University of Cambridge, Cambridge, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie O. M.","family":"Dyke","sequence":"additional","affiliation":[{"name":"1Department of Biochemistry, University of Cambridge, Cambridge, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair M.","family":"Moore","sequence":"additional","affiliation":[{"name":"1Department of Biochemistry, University of Cambridge, Cambridge, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindy L.","family":"Thomsen","sequence":"additional","affiliation":[{"name":"2Immunomodulation Section, Immunotherapeutics Department, GlaxoSmithKline, Stevenage, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Brindle","sequence":"additional","affiliation":[{"name":"1Department of Biochemistry, University of Cambridge, Cambridge, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2004,1,16]]},"reference":[{"key":"2022061620090267300_B1","unstructured":"Moncada S., Palmer R. M. J., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43:\u2008109-142, \u20081991."},{"key":"2022061620090267300_B2","doi-asserted-by":"crossref","unstructured":"Knowles R. G., Moncada S. Nitric oxide synthase in mammals. Biochem. J., 298:\u2008249-258, \u20081994.","DOI":"10.1042\/bj2980249"},{"key":"2022061620090267300_B3","doi-asserted-by":"crossref","unstructured":"Elfering S. L., Sarkela T. M., Giulivi C. Biochemistry of mitochondrial nitric-oxide synthase. J. Biol. Chem., 277:\u200838079-38086, \u20082002.","DOI":"10.1074\/jbc.M205256200"},{"key":"2022061620090267300_B4","doi-asserted-by":"crossref","unstructured":"Zhao H., Dugas N., Mathiot C., Delmer A., Dugas B., Sigaux F., Kolb J-P. B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity. Blood, 92:\u20081031-1043, \u20081998.","DOI":"10.1182\/blood.V92.3.1031"},{"key":"2022061620090267300_B5","doi-asserted-by":"crossref","unstructured":"Mannick J. B., Miao X. Q., Stamler J. S. Nitric oxide inhibits Fas-induced apoptosis. J. Biol. Chem., 272:\u200824125-24128, \u20081997.","DOI":"10.1074\/jbc.272.39.24125"},{"key":"2022061620090267300_B6","doi-asserted-by":"crossref","unstructured":"Arnold R. E., Weigent D. A. The production of nitric oxide in EL4 lymphoma cells overexpressing growth hormone. J. Neuroimmunol., 134:\u200882-94, \u20082003.","DOI":"10.1016\/S0165-5728(02)00420-4"},{"key":"2022061620090267300_B7","doi-asserted-by":"crossref","unstructured":"Fukumura D., Jain R. K. Role of nitric oxide in angiogenesis and microcirculation in tumors. Cancer Metastasis Rev., 17:\u200877-89, \u20081998.","DOI":"10.1023\/A:1005908805527"},{"key":"2022061620090267300_B8","doi-asserted-by":"crossref","unstructured":"Carmeliet P., Jain R. K. Angiogenesis in cancer and other diseases. Nature (Lond.), 407:\u2008249-257, \u20082000.","DOI":"10.1038\/35025220"},{"key":"2022061620090267300_B9","doi-asserted-by":"crossref","unstructured":"Xie K., Fidler I. J. Therapy of cancer metastasis by activation of the inducible nitric oxide synthase. Cancer Metastasis Rev., 17:\u200855-75, \u20081998.","DOI":"10.1023\/A:1005956721457"},{"key":"2022061620090267300_B10","doi-asserted-by":"crossref","unstructured":"Kwak J-Y., Han M. K., Choi K-S., Park I-H., Park S-Y., Sohn M-H., Kim U-H., McGregor J. R., Samlowski W. E., Yim C-Y. Cytokines secreted by lymphokine-activated killer cells induce endogenous nitric oxide synthesis and apoptosis in DLD-1 colon cancer cells. Cell. Immunol., 203:\u200884-94, \u20082000.","DOI":"10.1006\/cimm.2000.1682"},{"key":"2022061620090267300_B11","doi-asserted-by":"crossref","unstructured":"Lee V. Y., McClintock D. S., Santore M. T., Budinger G. R. S., Chandel N. S. Hypoxia sensitizes cells to nitric oxide-induced apoptosis. J. Biol. Chem., 277:\u200816067-16074, \u20082002.","DOI":"10.1074\/jbc.M111177200"},{"key":"2022061620090267300_B12","doi-asserted-by":"crossref","unstructured":"Jenkins D. C., Charles I. G., Thomsen L. L., Moss D. W., Holmes L. S., Baylis S. A., Rhodes P., Westmore K., Emson P. C., Moncada S. Roles of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. USA, 92:\u20084392-4396, \u20081995.","DOI":"10.1073\/pnas.92.10.4392"},{"key":"2022061620090267300_B13","doi-asserted-by":"crossref","unstructured":"Xie K., Huang S., Dong Z., Juang S-H., Gutman M., Xie Q-W., Nathan C., Fidler I. J. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J. Exp. Med., 181:\u20081333-1343, \u20081995.","DOI":"10.1084\/jem.181.4.1333"},{"key":"2022061620090267300_B14","doi-asserted-by":"crossref","unstructured":"Ambs S., Merriam W. G., Ogunfusika M. O., Bennett W. P., Ishibe N., Hussain S. P., Tzeng E. E., Geller D. A., Billiar T. R., Harris C. C. p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells. Nat. Med., 4:\u20081371-1376, \u20081998.","DOI":"10.1038\/3957"},{"key":"2022061620090267300_B15","unstructured":"Shi Q., Huang S., Jiang W., Kutach L. S., Ananthaswamy H. N., Xie K. Direct correlation between nitric oxide synthase II inducibility and metastatic ability of UV-2237 murine fibrosarcoma cells carrying mutant p53. Cancer Res., 59:\u20082072-2075, \u20081999."},{"key":"2022061620090267300_B16","doi-asserted-by":"crossref","unstructured":"Thomsen L., Miles D. W. Role of nitric oxide in tumour progression: lessons from human tumours. Cancer Metastasis Rev., 17:\u2008107-118, \u20081998.","DOI":"10.1023\/A:1005912906436"},{"key":"2022061620090267300_B17","unstructured":"Leek R. D., Lewis C. E., Whitehouse R., Greenall M., Clarke J., Harris A. L. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast cancer. Cancer Res., 56:\u20084625-4629, \u20081996."},{"key":"2022061620090267300_B18","doi-asserted-by":"crossref","unstructured":"Leek R. D., Lewis C. E., Harris A. L. The role of macrophages in tumour angiogenesis Bicknell R. Lewis C. E. Ferrara N. eds. . Tumour Angiogenesis, 81-99, Oxford University Press Oxford, England \u20081997.","DOI":"10.1093\/oso\/9780198549376.003.0008"},{"key":"2022061620090267300_B19","doi-asserted-by":"crossref","unstructured":"Stuehr D. J., Nathan C. F. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med., 169:\u20081543-1555, \u20081989.","DOI":"10.1084\/jem.169.5.1543"},{"key":"2022061620090267300_B20","unstructured":"Keller R., Geiges M., Keist R. L-arginine-dependent reactive nitrogen intermediates as mediators of tumor cell killing by activated macrophages. Cancer Res., 50:\u20081421-1425, \u20081990."},{"key":"2022061620090267300_B21","unstructured":"Cui S., Reichner J. S., Mateo R. B., Albina J. E. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res., 54:\u20082462-2467, \u20081994."},{"key":"2022061620090267300_B22","unstructured":"Ambs S., Merriam W. G., Bennett W. P., Felley-Bosco E., Ogunfusika M. O., Oser S. M., Klein S., Shields P. G., Billiar T. R., Harris C. C. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res., 58:\u2008334-341, \u20081998."},{"key":"2022061620090267300_B23","unstructured":"Yim C. Y., Bastian N. R., Smith J. C., Hibbs J. B., Samlowski W. E. Macrophage nitric oxide synthesis delays progression of ultraviolet light-induced murine skin cancers. Cancer Res., 53:\u20085507-5511, \u20081993."},{"key":"2022061620090267300_B24","doi-asserted-by":"crossref","unstructured":"Dinapoli M. R., Calderon C. L., Lopez D. M. The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduced expression of the inducible nitric oxide synthase gene. J. Exp. Med., 183:\u20081323-1329, \u20081996.","DOI":"10.1084\/jem.183.4.1323"},{"key":"2022061620090267300_B25","doi-asserted-by":"crossref","unstructured":"Hung K., Hayashi R., Lafond-Walker A., Lowenstein C., Pardoll D., Levitsky H. The central role of CD4+ T cells in the antitumor immune response. J. Exp. Med., 188:\u20082357-2368, \u20081998.","DOI":"10.1084\/jem.188.12.2357"},{"key":"2022061620090267300_B26","doi-asserted-by":"crossref","unstructured":"Amber I. J., Hibbs J. B. J., Taintor R. R., Vavrin Z. The L-arginine dependent effector mechanism is induced in murine adenocarcinoma cells by culture supernatant from cytotoxic activated macrophages. J. Leukocyte Biol., 43:\u2008187-192, \u20081988.","DOI":"10.1002\/jlb.43.2.187"},{"key":"2022061620090267300_B27","doi-asserted-by":"crossref","unstructured":"Moore M. W., Carbone F. R., Bevan M. J. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell, 54:\u2008777-785, \u20081988.","DOI":"10.1016\/S0092-8674(88)91043-4"},{"key":"2022061620090267300_B28","doi-asserted-by":"crossref","unstructured":"Laubach V. E., Shesely E. G., Smithies O., Sherman P. A. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc. Natl. Acad. Sci. USA, 92:\u200810688-10692, \u20081995.","DOI":"10.1073\/pnas.92.23.10688"},{"key":"2022061620090267300_B29","doi-asserted-by":"crossref","unstructured":"Huang P. L., Huang Z., Mashimo H., Bloch K. D., Moskowitz M. A., Bevan J. A., Fishman M. C. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature (Lond.), 377:\u2008239-242, \u20081995.","DOI":"10.1038\/377239a0"},{"key":"2022061620090267300_B30","doi-asserted-by":"crossref","unstructured":"Mosi R., Seguin B., Cameron B., Amankwa L., Darkes M. C., Fricker S. P. Mechanistic studies on AMD6221: a ruthenium-based nitric oxide scavenger. Biochem. Biophys. Res. Commun., 292:\u2008519-529, \u20082002.","DOI":"10.1006\/bbrc.2002.6685"},{"key":"2022061620090267300_B31","doi-asserted-by":"crossref","unstructured":"Sandhu J. K., Privora H. F., Wenckebach G., Birnboim H. C. Neutrophils, nitric oxide synthase, and mutations in the mutatect murine tumor model. Am. J. Pathol., 156:\u2008509-518, \u20082000.","DOI":"10.1016\/S0002-9440(10)64755-4"},{"key":"2022061620090267300_B32","doi-asserted-by":"crossref","unstructured":"Dyall R., Vasovic L. V., Clynes R. A., Nikolic-Zugic J. Cellular requirements for the monoclonal antibody-mediated eradication of an established solid tumour. Eur. J. Immunol., 29:\u200830-37, \u20081999.","DOI":"10.1002\/(SICI)1521-4141(199901)29:01<30::AID-IMMU30>3.0.CO;2-D"},{"key":"2022061620090267300_B33","unstructured":"Mayhew T. M., Sharma A. K. Sampling schemes for estimating nerve-fiber size.II.Methods for nerve trunks of mixed fascicularity. J. Anat., 139:\u200845-58, \u20081984."},{"key":"2022061620090267300_B34","doi-asserted-by":"crossref","unstructured":"Kimura M., Amemiya K., Yamada T., Suzuki J. Quantitative method for measuring adjuvant-induced granuloma angiogenesis in insulin-treated diabetic mice. J. Pharmacobio-Dyn., 9:\u2008442-446, \u20081986.","DOI":"10.1248\/bpb1978.9.442"},{"key":"2022061620090267300_B35","doi-asserted-by":"crossref","unstructured":"Hu D-E., Beauregard D. A., Bearchell M. C., Thomsen L. L., Brindle K. M. Early detection of tumour immune-rejection using magnetic resonance imaging. Br. J. Cancer, 88:\u20081135-1142, \u20082003.","DOI":"10.1038\/sj.bjc.6600814"},{"key":"2022061620090267300_B36","doi-asserted-by":"crossref","unstructured":"Misko T. P., Schilling R. J., Salvemini D., Moore W. M., Currie M. G. A fluorometric assay for measurement of nitrite in biological samples. Anal. Biochem., 214:\u200811-16, \u20081993.","DOI":"10.1006\/abio.1993.1449"},{"key":"2022061620090267300_B37","unstructured":"Ju D. W., Tao Q., Lou G., Bai M., He L., Yang Y., Cao X. Interleukin 18 transfection enhances anti-tumor immunity induced by dendritic cell-tumor cell conjugates. Cancer Res., 61:\u20083735-3740, \u20082001."},{"key":"2022061620090267300_B38","doi-asserted-by":"crossref","unstructured":"Ke Y., Ma H., Kapp J. A. Antigen is required for the activation of effector activities, whereas interleukin 2 is required for the maintenance of memory in ovalbumin-specific, CD8+ cytotoxic T lymphocytes. J. Exp. Med., 187:\u200849-57, \u20081998.","DOI":"10.1084\/jem.187.1.49"},{"key":"2022061620090267300_B39","doi-asserted-by":"crossref","unstructured":"Anthony M. L., Zhao M., Brindle K. M. Inhibition of phosphatidylcholine biosynthesis following induction of apoptosis in HL-60 cells. J. Biol. Chem., 274:\u200819686-19692, \u20081999.","DOI":"10.1074\/jbc.274.28.19686"},{"key":"2022061620090267300_B40","doi-asserted-by":"crossref","unstructured":"Brossart P., Goldrath A. W., Butz E. A., Martin S., Bevan M. J. Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. J. Immunol., 158:\u20083270-3276, \u20081997.","DOI":"10.4049\/jimmunol.158.7.3270"},{"key":"2022061620090267300_B41","doi-asserted-by":"crossref","unstructured":"Vasovic L. V., Dyall R., Clynes R. A., Ravetch J. V., Nikolic-Zugic J. Synergy between an antibody and CD8(+) cells in eliminating an established tumor. Eur. J. Immunol., 27:\u2008374-382, \u20081997.","DOI":"10.1002\/eji.1830270206"},{"key":"2022061620090267300_B42","unstructured":"Minev B. R., McFarland B. J., Spiess P. J., Rosenberg S. A., Restifo N. P. Insertion signal sequence fused to minimal peptides elicits specific Cd8+ T-cell responses and prolongs survival of thymoma-bearing mice. Cancer Res., 54:\u20084155-4161, \u20081994."},{"key":"2022061620090267300_B43","unstructured":"Zhou F., Rouse B. T., Huang L. Prolonged survival of thymoma-bearing mice after vaccination with a soluble-protein antigen entrapped in liposomes: a model study. Cancer Res., 52:\u20086287-6291, \u20081992."},{"key":"2022061620090267300_B44","doi-asserted-by":"crossref","unstructured":"Ramprasad M. P., Fischer W., Witztum J. L., Sambrano G. R., Quehenberger O., Steinberg D. The 94-Kda to 97-Kda mouse macrophage membrane-protein that recognizes oxidized low-density-lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homolog of human Cd68. Proc. Natl. Acad. Sci. USA, 92:\u20089580-9584, \u20081995.","DOI":"10.1073\/pnas.92.21.9580"},{"key":"2022061620090267300_B45","unstructured":"Gal A., Tamir S., Kennedy L. J., Tannenbaum S. R., Wogan G. N. Nitrotyrosine formation, apoptosis, and oxidative damage: relationships to nitric oxide production in SJL mice bearing the RcsX tumor. Cancer Res., 57:\u20081823-1828, \u20081997."},{"key":"2022061620090267300_B46","doi-asserted-by":"crossref","unstructured":"Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch. Biochem. Biophys., 356:\u20081-11, \u20081998.","DOI":"10.1006\/abbi.1998.0755"},{"key":"2022061620090267300_B47","unstructured":"Thomsen L. L., Scott J. M. J., Topley P., Knowles R. G., Keerie A-J., Frend A. J. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res., 57:\u20083300-3304, \u20081997."},{"key":"2022061620090267300_B48","doi-asserted-by":"crossref","unstructured":"Pieper G. M., Roza A. M., Adams M. B., Hilton G., Johnson M., Felix C. C., Kampalath B., Darkes M., Wanggui Y., Cameron B., Fricker S. P. A ruthenium (III) polyaminocarboxylate complex, a novel nitric oxide scavenger, enhances graft survival and decreases nitrosylated heme protein in models of acute and delayed cardiac transplant rejection. J. Cardiovasc. Pharmacol., 39:\u2008441-448, \u20082002.","DOI":"10.1097\/00005344-200203000-00016"},{"key":"2022061620090267300_B49","doi-asserted-by":"crossref","unstructured":"Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J., 6:\u20083051-3064, \u20081992.","DOI":"10.1096\/fasebj.6.12.1381691"},{"key":"2022061620090267300_B50","doi-asserted-by":"crossref","unstructured":"Chin K., Kurashima Y., Ogura T., Tajiri H., Yoshida S., Esumi H. Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells. Oncogene, 15:\u2008437-442, \u20081997.","DOI":"10.1038\/sj.onc.1201201"},{"key":"2022061620090267300_B51","doi-asserted-by":"crossref","unstructured":"Ziche M., Morbidelli L., Choudhuri R., Zhang H-T., Donnini S., Granger H. J., Bicknell R. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J. Clin. Investig., 99:\u20082625-2634, \u20081997.","DOI":"10.1172\/JCI119451"},{"key":"2022061620090267300_B52","doi-asserted-by":"crossref","unstructured":"Thomsen L. L., Miles D. W., Happerfield L., Bobrow L. G., Knowles R. G., Moncada S. Nitric oxide synthase activity in human breast cancer. Br. J. Cancer, 72:\u200841-44, \u20081995.","DOI":"10.1038\/bjc.1995.274"},{"key":"2022061620090267300_B53","unstructured":"Thomsen L. L., Lawton F. G., Knowles R. G., Beesley J. E., Riveros-Moreno V., Moncada S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res., 54:\u20081352-1354, \u20081994."},{"key":"2022061620090267300_B54","unstructured":"Dong Z., Staroselsky A. H., Qi X., Xie K., Fidler I. J. Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res., 54:\u2008789-793, \u20081994."},{"key":"2022061620090267300_B55","doi-asserted-by":"crossref","unstructured":"Bogdan C. Nitric oxide and the immune response. Nat. Immunol., 2:\u2008907-916, \u20082001.","DOI":"10.1038\/ni1001-907"},{"key":"2022061620090267300_B56","doi-asserted-by":"crossref","unstructured":"Rosenberg S. A. Progress in human tumour immunology and immunotherapy. Nature (Lond.), 411:\u2008380-384, \u20082001.","DOI":"10.1038\/35077246"},{"key":"2022061620090267300_B57","doi-asserted-by":"crossref","unstructured":"Shrikant P., Mescher M. F. Control of syngeneic tumor growth by activation of CD8+ T cells: efficacy is limited by migration away from the site and induction of nonresponsiveness. J. Immunol., 162:\u20082858-2866, \u20081999.","DOI":"10.4049\/jimmunol.162.5.2858"},{"key":"2022061620090267300_B58","unstructured":"Brown G. C., Borutaite V. Nitric oxide inhibition of mitochondrial respiration and its role in cell death. Free Radic. Biol. Med., 26:\u2008925-935, \u20082002."},{"key":"2022061620090267300_B59","unstructured":"Konopka T. E., Barker J. E., Bamford T. L., Guida E., Anderson R. L., Stewart A. G. Nitric oxide synthase II gene disruption: implications for tumor growth and vascular endothelial growth factor production. Cancer Res., 61:\u20083182-3187, \u20082001."},{"key":"2022061620090267300_B60","unstructured":"Shi Q., Xiong Q., Wang B., Le X., Khan N. A., Xie K. Influence of nitric oxide synthase II gene disruption on tumor growth and metastasis. Cancer Res., 60:\u20082579-2583, \u20082000."},{"key":"2022061620090267300_B61","doi-asserted-by":"crossref","unstructured":"Wang B., Xiong Q., Shi Q., Tan D., Le X., Xie K. Genetic disruption of host nitrix oxide synthase II gene impairs melanoma-induced angiogenesis and suppresses pleural effusion. Int. J. Cancer, 91:\u2008607-611, \u20082001.","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1109>3.0.CO;2-D"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/64\/1\/152\/2513903\/zch00104000152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/64\/1\/152\/2513903\/zch00104000152.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T03:12:55Z","timestamp":1706584375000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/64\/1\/152\/511201\/Tumor-Cell-Derived-Nitric-Oxide-Is-Involved-in-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,1]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,1,16]]},"published-print":{"date-parts":[[2004,1,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-03-1807","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1,1]]}}}